Industry Spotlight

Sinodinos: We have to get better at collaboration

23 March 2017 via Biotech Dispatch: Investment in innovation and collaboration between researchers, industry and government is essential, according to minister for industry, innovation and science, Senator Arthur Sinodinos AO. During an address to the National Press... | READ MORE

Turnbull government unveils National Science Statement

23 March 2017 via Biotech Dispatch: The Turnbull government has unveiled its National Science Statement. The statement, which focuses on the long-term importance of science to the economy and wider society, articulates governments vision and objectives for Australia... | READ MORE

Clarity establishes European subsidiary

21 March 2017 via Biotech Dispatch: Clarity Pharmaceuticals, which specialises in medical imaging, has officially established a European subsidiary - Clarity Pharmaceuticals Europe SA. The Sydney-based company created in 2010 has formed a partnership with ANMI, a co... | READ MORE

TGA reforms one step closer

21 march 2017 via Biotech Dispatch: Legislation giving effect to governments response to the review of medicines and medical device regulation is one step closer after last Fridays public hearing of the Senate Inquiry. The Community Affairs Legislation Committee spe... | READ MORE

Food manufacturing executive appointed to lead TechInSA

14 March 2017 via Biotech Dispatch: Experienced manufacturing and international distribution executive Joe Thorp has been appointed as the new Chief Executive for TechInSA, a State Government agency that works with the hi-tech sector to bring innovative products and ... | READ MORE

Key leadership changes for Novogen

14 March 2017 via Biotech Dispatch: Australian oncology-focused biotechnology company Novogen (ASX:NRT) has announced changes to the companys senior management it says are designed to support the its transformation from a discovery research organisation to one focuse... | READ MORE

TGA approval for Actinogen Medical’s XanADu trial

9 March 2017 via Biotech Dispatch: Actinogen Medical (ASX: ACW) has announced TGA approval to conduct XanADu, its phase 2 clinical trial of its drug candidate, Xanamem. The TGA approval follows similar approvals from the US FDA and the Medicines and Healthcare produ... | READ MORE

Government grants first licence to grow and harvest medicinal cannabis

9 March 2017 via Biotech Dispatch: Health minister Greg Hunt has announced government has granted the first licence for an Australian company to grow and harvest medicinal cannabis. The Department of Healths Office of Drug Control has issued the licence under the me... | READ MORE

Medlab signs agreement for new study

7 March 2017 via Biotech Dispatch: Medical life science company, Medlab Clinical Limited (ASX:MDC), has signed an agreement to initiate a study to compare how its NanoCelle Atorvastatin oral spray, called NanoStat, patent pending, compares with taking statin tablets,... | READ MORE

Another anti-PD-L1 cancer therapy emerging

7 March 2017 via Biotech Dispatch: A major development for patients with urothelial carcinoma with Merck and Pfizer announcing they have submitted avelumab to the FDA. It has priority review status by the FDA, which could reduce the review time to six months, having... | READ MORE

Previous page | Next page
Jump to page